Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families

Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26

(2012) Ziad J. Sahab et al.   Journal of Cancer

Mutations in the 5′ UTR of ANKRD26, the Ankirin Repeat Domain 26 Gene, Cause an Autosomal-Dominant Form of Inherited Thrombocytopenia, THC2

(2011) Tommaso Pippucci et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations

(2010) A. Pecci et al.   BLOOD

A mutation in the acyl-coenzyme A binding domain-containing protein 5 gene (ACBD5 ) identified in autosomal dominant thrombocytopenia

(2010) F. PUNZO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Advances in the understanding of congenital amegakaryocytic thrombocytopenia

(2009) Matthias Ballmaier et al.   BRITISH JOURNAL OF HAEMATOLOGY

Congenital Amegakaryocytic Thrombocytopenia and Thrombocytopenia with Absent Radii

(2009) Amy E. Geddis   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia

(2009) P. NORIS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Insights into Familial Platelet Disorder with Propensity to Myeloid Malignancy (FPD/AML)

(2009) Carolyn Owen   LEUKEMIA RESEARCH

Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

(2009) Elaine R. Mardis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)

(2008) A. Pecci et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history ofMYH9-related disease

(2007) Alessandro Pecci et al.   HUMAN MUTATION